Más de miocardiopatía periparto/More on peripartum cardiomyopathy

Cardiomiopatía periparto: una revisión  Peripartum cardiomyopathy: a review. Capriola M. Thomasville Medical Center, Department of Emergency Medicine, Thomasville Medical Center, Thomasville, NC, USA. Int J Womens Health. 2013;5:1-8. doi: 10.2147/IJWH.S37137. Epub 2012 Dec 28. Abstract Peripartum cardiomyopathy (PPCM) is a form of dilated cardiomyopathy of unclear etiology affecting women without preexisting heart disease during the last month of pregnancy or during the first 5 months postpartum. Its incidence shows marked geographic and ethnic variation, being most common in Africa and among women of African descent. Most women present in the first month postpartum with typical heart failure symptoms such as dyspnea, lower extremity edema, and fatigue. These symptoms are often initially erroneously diagnosed as part of the normal puerperal process. Diagnosis can be aided by the finding of a significantly elevated serum brain natriuretic peptide. The etiology of PPCM is unclear; however, recent research suggests abnormal prolactin metabolism is seminal in its development, and prolactin antagonism with bromocriptine shows promise as a novel treatment for PPCM. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536353/pdf/ijwh-5-001.pdf     Curso clínico variable de la cardiomiopatía periparto  The variable clinical course of peripartum cardiomyopathy. Krejci J, Hude P, Spinarova L, Zampachova V, Sirotkova A, Freiberger T, Nemcova E, Vitovec J. International Clinical Research Center - 1st Internal Cardio-Angiological Clinic, St. Anne's University Hospital Brno, Czech Republic. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2012 Oct 31. doi: 10.5507/bp.2012.080. Abstract BACKGROUND: In Europe, peripartum cardiomyopathy (PPCM) is a rare disorder, often difficult to diagnose and it has a variable clinical course. The aim of this report was to describe and discuss the individual variability of this disorder and its management. PATIENTS AND METHODS: Three cases of PPCM manifesting as severe heart failure are compared. Common was the presence of myocardial inflammation detected by endomyocardial biopsy. Different were treatment methods and clinical course. Modern therapeutic concepts such as immunosuppressive therapy and bromocriptin administration are discussed, as well as non-pharmacological approaches. CONCLUSION: In the differential diagnostics of dyspnea associated with pregnancy and childbirth, PPCM should be considered. The potentially severe course of the disease requires hospitalization with the possibility of comprehensive heart failure treatment, including non-pharmacological approaches such as device therapy and heart transplantation. http://biomed.papers.upol.cz/getrevsrc.php?identification=public&mag=bio&raid=413&type=fin&ver=2     Una emergencia obstétrica llamada cardiomiopatía periparto  An obstetric emergency called peripartum cardiomyopathy! Shaikh N. Department of Anesthesia/ICU and Pain Management, Hamad Medical Corporation, Doha-Qatar. J Emerg Trauma Shock. 2010 Jan;3(1):39-42. doi: 10.4103/0974-2700.58664. Abstract Peripartum cardiomyopathy (PPCM) is a rare obstetric emergency affecting women in late pregnancy or up to five months of postpartum period. The etiology of PPCM is still not known. It has potentially devastating effects on mother and fetus if not treated early. The signs, symptoms and treatment of PPCM are similar to that of heart failure. Early diagnosis and proper management is the corner stone for better outcome of these patients. The only way to prevent PPCM is to avoid further pregnancies. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823141/  Atentamente Anestesiología y Medicina del Dolor www.anestesia-dolor.org